121 related articles for article (PubMed ID: 1574922)
21. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A.
Tsujimoto M; Kotani S; Okunaga T; Kubo T; Takada H; Kubo T; Shiba T; Kusumoto S; Takahashi T; Goto Y
Vaccine; 1989 Feb; 7(1):39-48. PubMed ID: 2718605
[TBL] [Abstract][Full Text] [Related]
22. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.
Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W
Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802
[TBL] [Abstract][Full Text] [Related]
23. Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum.
Hunsmann G; Moennig V; Schäfer W
Virology; 1975 Jul; 66(1):327-9. PubMed ID: 1136142
[No Abstract] [Full Text] [Related]
24. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
[TBL] [Abstract][Full Text] [Related]
25. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice.
Ishihara C; Mizukoshi N; Iida J; Kato K; Yamamoto K; Azuma I
Vaccine; 1987 Dec; 5(4):295-301. PubMed ID: 2448969
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
28. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
Chang YH; Pearson CM; Chedid L
J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
[TBL] [Abstract][Full Text] [Related]
30. Restriction of Friend virus-induced erythroid cell proliferation by CD4+ T-lymphocytes that recognize a single gp70 epitope.
Miyazawa M; Fujisawa R
Leukemia; 1997 Apr; 11 Suppl 3():227-9. PubMed ID: 9209349
[TBL] [Abstract][Full Text] [Related]
31. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
32. Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants.
Siddiqui WA; Taylor DW; Kan SC; Kramer K; Richmond-Crum SM; Kotani S; Shiba T; Kasumoto S
Bull World Health Organ; 1979; 57 Suppl 1(Suppl):199-203. PubMed ID: 120768
[TBL] [Abstract][Full Text] [Related]
33. Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes.
Hunsmann G; Schneider J; Schulz A
Virology; 1981 Sep; 113(2):602-12. PubMed ID: 6943864
[No Abstract] [Full Text] [Related]
34. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
35. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
36. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
Ishihara C; Yamamoto K; Hamada N; Azuma I
Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
[TBL] [Abstract][Full Text] [Related]
37. Effect of a synthetic adjuvant for inducing anti-tumour immunity.
Kataoka T; Kinomoto M; Takegawa M; Tokunaga T
Vaccine; 1991 May; 9(5):300-2. PubMed ID: 1872013
[TBL] [Abstract][Full Text] [Related]
38. Friend murine leukemia virus-induced leukemia is associated with the formation of mink cell focus-inducing viruses and is blocked in mice expressing endogenous mink cell focus-inducing xenotropic viral envelope genes.
Ruscetti S; Davis L; Feild J; Oliff A
J Exp Med; 1981 Sep; 154(3):907-20. PubMed ID: 6268733
[TBL] [Abstract][Full Text] [Related]
39. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus.
Fukushima A; Yoo YC; Yoshimatsu K; Matsuzawa K; Tamura M; Tono-oka S; Taniguchi K; Urasawa S; Arikawa J; Azuma I
Vaccine; 1996 Apr; 14(6):485-91. PubMed ID: 8782344
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of immunization with nonviral antigens against Friend leukemia virus in mice.
Nahon-Merlin E; Lacour F; Friend C; Revoltella R
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2018-21. PubMed ID: 287040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
